CORREVIO PHARMA CORP's ticker is CORV and the CUSIP is 22026V105. A total of 31 filers reported holding CORREVIO PHARMA CORP in Q4 2019. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $6,000 | – | 15,101 | +1230.5% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 1,135 | +24.7% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 910 | -4.1% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 949 | +21.2% | 0.00% | – |
| Q1 2019 | $2,000 | -33.3% | 783 | -27.2% | 0.00% | – |
| Q4 2018 | $3,000 | 0.0% | 1,075 | +59.3% | 0.00% | – |
| Q3 2018 | $3,000 | -25.0% | 675 | -31.3% | 0.00% | – |
| Q2 2018 | $4,000 | – | 983 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|